Spots Global Cancer Trial Database for stage iv ovarian germ cell tumor

Every month we try and update this database with for stage iv ovarian germ cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors	NCT00006036	Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	cisplatin lurtotecan lipo...	18 Years - 120 Years	Canadian Cancer Trials Group
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer	NCT00601406	Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer	gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera...	-	National Cancer Institute (NCI)
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	NCT02122185	Brenner Tumor Malignant Ascit... Malignant Pleur... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Serous ... Ovarian Undiffe... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar...	metformin hydro... placebo Chemotherapy	18 Years -	University of Chicago
Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer	NCT00337233	Breast Cancer Fatigue Ovarian Cancer Psychosocial Ef...	yoga therapy	18 Years - 120 Years	Wake Forest University Health Sciences
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery	NCT02013492	Male Breast Can... Recurrent Melan... Stage IV Breast... Stage IV Melano... Stage IV Ovaria... Stage IV Ovaria... Unspecified Adu... Hepatocellular ...	propranolol hyd... Correlative Stu...	18 Years -	Ohio State University Comprehensive Cancer Center
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors	NCT01233505	Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu...	veliparib capecitabine oxaliplatin pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer	NCT00898781	Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc...		-	Mayo Clinic
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer	NCT00287885	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer	docetaxel	18 Years -	Masonic Cancer Center, University of Minnesota
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers	NCT00684801	Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	questionnaire a... quality-of-life...	18 Years -	Case Comprehensive Cancer Center
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer	NCT00003794	Ovarian Cancer	psychosocial as... quality-of-life...	18 Years -	GOG Foundation
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer	NCT00898781	Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc...		-	Mayo Clinic
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	NCT01126346	Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi...	HIPEC Orientati... Consultation wi... Questionnaires	-	Wake Forest University Health Sciences
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment	NCT00453310	Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ...	sunitinib malat...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function	NCT00002901	Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	docetaxel	18 Years -	City of Hope Medical Center
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors	NCT00003173	Brain and Centr... Childhood Germ ... Extragonadal Ge... Ovarian Cancer Retinoblastoma Testicular Germ... Unspecified Adu... Unspecified Chi...	filgrastim thiotepa autologous bone... peripheral bloo...	-	Memorial Sloan Kettering Cancer Center
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	NCT01126346	Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi...	HIPEC Orientati... Consultation wi... Questionnaires	-	Wake Forest University Health Sciences
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer	NCT00253708	Cancer	management of t... massage therapy pain therapy psychosocial as... quality-of-life...	18 Years - 120 Years	Beth Israel Deaconess Medical Center
Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer	NCT00005807	Breast Cancer Ovarian Cancer Unspecified Adu...	BMS-247550	18 Years - 120 Years	Albert Einstein College of Medicine
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer	NCT01927393	Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Stage III Pancr... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IIIC Ovar... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre...	palliative care educational int... quality-of-life... questionnaire a... telephone-based...	21 Years -	City of Hope Medical Center
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors	NCT00667641	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu...	bortezomib paclitaxel	18 Years -	Rutgers, The State University of New Jersey
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer	NCT00898781	Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc...		-	Mayo Clinic
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors	NCT00551122	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel	16 Years - 60 Years	University of Southampton
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	NCT01126346	Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi...	HIPEC Orientati... Consultation wi... Questionnaires	-	Wake Forest University Health Sciences
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors	NCT00957905	Recurrent Extra... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Stage III Testi... Stage IV Extrag... Stage IV Extrag... Stage IV Ovaria...	Alvocidib Hydro... Fluorouracil Leucovorin Calc... Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer	NCT00905658	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	therapeutic nut... standard follow...	18 Years - 65 Years	National Cancer Institute (NCI)
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors	NCT00006036	Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu...	cisplatin lurtotecan lipo...	18 Years - 120 Years	Canadian Cancer Trials Group
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	NCT00087191	Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga...	EF5 motexafin lutet... pharmacological...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors	NCT00002489	Extragonadal Ge... Ovarian Cancer	dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide leucovorin calc... methotrexate vincristine sul... conventional su...	- 20 Years	Memorial Sloan Kettering Cancer Center
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors	NCT00551122	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel	16 Years - 60 Years	University of Southampton
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer	NCT00601406	Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer	gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera...	-	National Cancer Institute (NCI)
Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer	NCT00856453	Depression Fatigue Ovarian Cancer	Home yoga pract... yoga classes	18 Years - 120 Years	Wake Forest University Health Sciences
Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer	NCT00003763	Ovarian Cancer	radionuclide im... indium In 111 f...	18 Years - 120 Years	Endocyte
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors	NCT01172028	Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer	Taxotere (Docet... Alimta (Pemetre...	18 Years -	University of Arizona
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors	NCT00070096	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	ixabepilone	16 Years -	National Cancer Institute (NCI)
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine	NCT00228358	HER2-positive B... Recurrent Breas... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Stage IV Breast... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria...	ex vivo-expande... cyclophosphamid... denileukin dift... flow cytometry immunoenzyme te...	18 Years -	University of Washington
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
11C Topotecan PET Imaging	NCT00253461	Lung Cancer Metastatic Canc... Ovarian Cancer Unspecified Adu...	computed tomogr... positron emissi... 11C topotecan fludeoxyglucose...	18 Years -	Case Comprehensive Cancer Center
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00083213	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer	NCT00436254	HER2-positive B... Stage III Ovari... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Stage IV Ovaria...	pNGVL3-hICD vac... sargramostim flow cytometry immunologic tec... immunoenzyme te... protein express... biopsy	18 Years -	University of Washington
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer	NCT00436254	HER2-positive B... Stage III Ovari... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Stage IV Ovaria...	pNGVL3-hICD vac... sargramostim flow cytometry immunologic tec... immunoenzyme te... protein express... biopsy	18 Years -	University of Washington
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer	NCT00005858	Bladder Cancer Breast Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	LMB-9 immunotox...	18 Years -	University of Maryland, Baltimore
Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors	NCT00002489	Extragonadal Ge... Ovarian Cancer	dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide leucovorin calc... methotrexate vincristine sul... conventional su...	- 20 Years	Memorial Sloan Kettering Cancer Center
Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer	NCT01322802	Stage III Ovari... Stage III Ovari... Stage IV Ovaria... Stage IV Ovaria...	pUMVC3-hIGFBP-2... laboratory biom...	18 Years -	University of Washington
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors	NCT01131234	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Solid Neo... Male Breast Car... Recurrent Adult... Recurrent Breas... Recurrent Colon... Recurrent Melan... Recurrent Non-S... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Stage III Pancr... Stage III Renal... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Skin... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Skin... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Skin... Stage IV Breast... Stage IV Non-Sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Skin M... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Gamma-Secretase... Cediranib Malea... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer	NCT01132547	Cancer	cyproheptadine ... placebo	2 Years - 21 Years	University of South Florida
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer	NCT01212887	Breast Cancer Colorectal Canc... Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Canc... Unspecified Adu...	MFE23 scFv-expr... aldesleukin cyclophosphamid... fludarabine pho... laboratory biom... pharmacological...	18 Years -	Cancer Research UK
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer	NCT00905658	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	therapeutic nut... standard follow...	18 Years - 65 Years	National Cancer Institute (NCI)
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin	NCT00423852	Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ...	filgrastim carboplatin ifosfamide paclitaxel autologous hema... peripheral bloo...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors	NCT01172028	Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer	Taxotere (Docet... Alimta (Pemetre...	18 Years -	University of Arizona
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers	NCT00684801	Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	questionnaire a... quality-of-life...	18 Years -	Case Comprehensive Cancer Center
Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer	NCT00652899	Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	Allopurinol Cyclophosphamid... Fludarabine pho... total-body irra... Allogeneic natu... Aldesleukin	18 Years -	Masonic Cancer Center, University of Minnesota
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer	NCT00383279	Cervical Cancer Ovarian Cancer Sarcoma	counseling inte... study of socioe...	18 Years - 120 Years	Wake Forest University Health Sciences
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors	NCT00313599	Bladder Cancer Brain and Centr... Breast Cancer Esophageal Canc... Extragonadal Ge... Gastric Cancer Lung Cancer Ovarian Cancer Prostate Cancer	lapatinib paclitaxel	18 Years -	University of California, San Francisco
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer	NCT00002931	Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ...	filgrastim carboplatin etoposide ifosfamide paclitaxel autologous bone... bone marrow abl...	16 Years - 120 Years	City of Hope Medical Center
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer	NCT00004065	Bladder Cancer Breast Cancer Colorectal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Lung Cancer Melanoma (Skin) Ovarian Cancer Prostate Cancer Unspecified Adu...	tanespimycin	18 Years -	Memorial Sloan Kettering Cancer Center
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers	NCT00684801	Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc...	questionnaire a... quality-of-life...	18 Years -	Case Comprehensive Cancer Center
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer	NCT00055705	Cancer	PV701	18 Years -	National Cancer Institute (NCI)
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer	NCT00898781	Breast Cancer Colorectal Canc... Ovarian Cancer Pancreatic Canc...		-	Mayo Clinic
Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin	NCT00006043	Ovarian Cancer Testicular Germ...	temozolomide	16 Years -	Memorial Sloan Kettering Cancer Center
Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors	NCT00957905	Recurrent Extra... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Stage III Testi... Stage IV Extrag... Stage IV Extrag... Stage IV Ovaria...	Alvocidib Hydro... Fluorouracil Leucovorin Calc... Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer	NCT00003532	Stage III Ovari... Stage IV Ovaria...	Antineoplaston ...	18 Years - 99 Years	Burzynski Research Institute
Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer	NCT00002943	Extragonadal Ge... Ovarian Cancer Testicular Germ... Unspecified Adu...	carboplatin cyclophosphamid... etoposide autologous bone...	18 Years - 120 Years	Wake Forest University Health Sciences
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy	NCT01080521	Cognitive Side ... Malignant Ovari... Ovarian Brenner... Ovarian Carcino... Ovarian Chorioc... Ovarian Clear C... Ovarian Dysgerm... Ovarian Embryon... Ovarian Endomet... Ovarian Mixed G... Ovarian Mucinou... Ovarian Polyemb... Ovarian Sarcoma Ovarian Seromuc... Ovarian Serous ... Ovarian Teratom... Ovarian Yolk Sa... Stage I Ovarian... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Ovaria... Stage IV Primar... Undifferentiate...	Cognitive Asses... Quality-of-Life...	18 Years -	GOG Foundation
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery	NCT02013492	Male Breast Can... Recurrent Melan... Stage IV Breast... Stage IV Melano... Stage IV Ovaria... Stage IV Ovaria... Unspecified Adu... Hepatocellular ...	propranolol hyd... Correlative Stu...	18 Years -	Ohio State University Comprehensive Cancer Center
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors	NCT00313599	Bladder Cancer Brain and Centr... Breast Cancer Esophageal Canc... Extragonadal Ge... Gastric Cancer Lung Cancer Ovarian Cancer Prostate Cancer	lapatinib paclitaxel	18 Years -	University of California, San Francisco
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors	NCT00070096	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	ixabepilone	16 Years -	National Cancer Institute (NCI)
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors	NCT00551122	Brain and Centr... Extragonadal Ge... Ovarian Cancer Testicular Germ...	filgrastim lenograstim pegfilgrastim cisplatin gemcitabine hyd... ifosfamide paclitaxel	16 Years - 60 Years	University of Southampton
Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer	NCT01494012	Recurrent Ovari... Recurrent Ovari... Malignant Tumor... Stage IV Ovaria... Stage IV Ovaria...	stereotactic bo... positron emissi... computed tomogr... questionnaire a... fludeoxyglucose...	18 Years -	Stanford University
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: